Catherine Novack
Stock Analyst at Jones Trading
(1.31)
# 3,566
Out of 4,873 analysts
22
Total ratings
17.65%
Success rate
-9.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $10.42 | +187.91% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $10.05 | +188.56% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.98 | +512.37% | 2 | May 13, 2025 | |
| RGLS Regulus Therapeutics | Downgrades: Hold | $8 → $7 | $8.16 | -14.22% | 2 | Apr 30, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.35 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $21.37 | +110.58% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.16 | +409.26% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $11.94 | +988.78% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.33 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $6.85 | +133.58% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $3.25 | +330.77% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.64 | +392.42% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $4.33 | +130.95% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $1.57 | +1,301.27% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.11 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $2.35 | +6,708.51% | 1 | Jul 21, 2023 |
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $10.42
Upside: +187.91%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $10.05
Upside: +188.56%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.98
Upside: +512.37%
Regulus Therapeutics
Apr 30, 2025
Downgrades: Hold
Price Target: $8 → $7
Current: $8.16
Upside: -14.22%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.35
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $21.37
Upside: +110.58%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.16
Upside: +409.26%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $11.94
Upside: +988.78%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.33
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $6.85
Upside: +133.58%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.25
Upside: +330.77%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.64
Upside: +392.42%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $4.33
Upside: +130.95%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $1.57
Upside: +1,301.27%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.11
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $2.35
Upside: +6,708.51%